Gladius Pharmaceuticals
About:
Gladius Pharmaceuticals is a biotechnology firm developing novel drugs to treat life-threatening
Website: http://gladiuspharma.com
Top Investors: Fonds de solidarité FTQ, SR One, Lumira Ventures, GlaxoSmithKline
Description:
Gladius Pharmaceuticals Inc., a Montréal-based biotechnology firm developing novel drugs to treat life-threatening, multi-drug-resistant bacterial infections.Gladius is a disruptive platform technology play, capable of developing multiple novel drug candidates
Total Funding Amount:
4.1M CAD
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Montréal, Quebec, Canada
Founded Date:
2015-01-01
Founders:
Larry Sutton
Number of Employees:
11-50
Last Funding Date:
2018-11-14
IPO Status:
Private
Industries:
© 2025 bioDAO.ai